1. Home
  2. NVCT vs TOYO Comparison

NVCT vs TOYO Comparison

Compare NVCT & TOYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVCT
  • TOYO
  • Stock Information
  • Founded
  • NVCT 2020
  • TOYO 2022
  • Country
  • NVCT United States
  • TOYO Japan
  • Employees
  • NVCT N/A
  • TOYO N/A
  • Industry
  • NVCT Medicinal Chemicals and Botanical Products
  • TOYO
  • Sector
  • NVCT Health Care
  • TOYO
  • Exchange
  • NVCT Nasdaq
  • TOYO NYSE
  • Market Cap
  • NVCT 184.9M
  • TOYO 153.8M
  • IPO Year
  • NVCT 2022
  • TOYO N/A
  • Fundamental
  • Price
  • NVCT $8.13
  • TOYO $3.73
  • Analyst Decision
  • NVCT Strong Buy
  • TOYO
  • Analyst Count
  • NVCT 3
  • TOYO 0
  • Target Price
  • NVCT $17.00
  • TOYO N/A
  • AVG Volume (30 Days)
  • NVCT 97.5K
  • TOYO 17.9K
  • Earning Date
  • NVCT 08-05-2025
  • TOYO 05-15-2025
  • Dividend Yield
  • NVCT N/A
  • TOYO N/A
  • EPS Growth
  • NVCT N/A
  • TOYO 350.49
  • EPS
  • NVCT N/A
  • TOYO 1.09
  • Revenue
  • NVCT N/A
  • TOYO $176,957,128.00
  • Revenue This Year
  • NVCT N/A
  • TOYO N/A
  • Revenue Next Year
  • NVCT N/A
  • TOYO N/A
  • P/E Ratio
  • NVCT N/A
  • TOYO $3.43
  • Revenue Growth
  • NVCT N/A
  • TOYO 183.69
  • 52 Week Low
  • NVCT $4.44
  • TOYO $1.36
  • 52 Week High
  • NVCT $11.80
  • TOYO $8.34
  • Technical
  • Relative Strength Index (RSI)
  • NVCT 37.24
  • TOYO N/A
  • Support Level
  • NVCT $8.79
  • TOYO N/A
  • Resistance Level
  • NVCT $9.30
  • TOYO N/A
  • Average True Range (ATR)
  • NVCT 0.50
  • TOYO 0.00
  • MACD
  • NVCT -0.11
  • TOYO 0.00
  • Stochastic Oscillator
  • NVCT 12.43
  • TOYO 0.00

About NVCT Nuvectis Pharma Inc.

Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.

About TOYO TOYO CO LTD

Toyo Co Ltd along with its subsidiaries, is engaged in research and development, production, and sales of solar cells. Geographically, the company generates revenue from Asia and the USA, out of which the majority of revenue is generated from Asia.

Share on Social Networks: